ethyl 8-phenyloctanoate | 134520-00-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: ethyl 8-phenyloctanoate
• CAS: 134520-00-6
• 化学式: C₁₆H₂₄O₂
• 分子量: 248.365
• InChiKey: RPSKTFFCRDLSRH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  18
• 可旋转键数：
  10
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  ethyl 8-phenyloctanoate 在 lithium aluminium tetrahydride 、 四溴化碳 、 三苯基膦 作用下， 生成 1-溴-8-苯基辛烷
  参考文献：
  名称：

  New Asymmetric Synthesis of Enantiomeric Pairs of the 2-Substituted Pyrrolidines Bgugaine and Irniine

  摘要：

  A new asymmetric route to 2-substituted pyrrolidines starting with the Sharpless asymmetric dihydroxylation (AD) of 4-pentenylphthalimide (5) followed by aminocyclization of the resultant amino alcohol is presented. The application to the asymmetric synthesis has been examined for two 2-substituted pyrrolidine alkaloids, bgugaine (1) and irniine (2).

  DOI：

  10.3987/com-97-s26
• 作为产物：
  描述：

  6-氯-6-氧代己酸乙酯 在 盐酸 、 cadmium(II) chloride 、 锌 作用下， 生成 ethyl 8-phenyloctanoate
  参考文献：
  名称：

  New Asymmetric Synthesis of Enantiomeric Pairs of the 2-Substituted Pyrrolidines Bgugaine and Irniine

  摘要：

  A new asymmetric route to 2-substituted pyrrolidines starting with the Sharpless asymmetric dihydroxylation (AD) of 4-pentenylphthalimide (5) followed by aminocyclization of the resultant amino alcohol is presented. The application to the asymmetric synthesis has been examined for two 2-substituted pyrrolidine alkaloids, bgugaine (1) and irniine (2).

  DOI：

  10.3987/com-97-s26

文献信息

• Quaternary ammonium compounds having muscle relaxation activity
  申请人：Tobishi Yakuhin Kogyo Kabushiki Kaisha

  公开号：US05093370A1

  公开（公告）日：1992-03-03

  A quaternary ammonium having a muscle relaxation activity compound represented by the formula (I): ##STR1## wherein R.sub.1 represents a methylene, a lower alkylenoxy, a lower alkenylene, a lower alkynylene, --CO--, --COO--, a lower alkylene carbonyloxy, --CH(OR.sub.5)--, a lower alkylenecarbonyl, a hydroxy lower alkylene, --O--, --S--, --SO--, or --SO.sub.2 --; R.sub.2 represents a hydrogen atom, a hydroxy lower alkyl, an aldehyde, a lower alkyl carbonyl, --NO.sub.2, or --NHR.sub.6 ; R.sub.3 represents a hydrogen atom of a group --R.sub.1 --(CH.sub.2).sub.a --[CH(CH.sub.2 A)--CH.sub.2 ].sub.b --A; R.sub.4 represents an anion; R.sub.5 and R.sub.6 represent a hydrogen atom or a acetyl; A represents a quaternary ammonium group; a represents an integer of 1 to 8; b represents 0 or 1; m represents an integer of 1 to 4; and (Z) represents a trivalent benzene ring, a trivalent naphthalene ring, a trivalent diphenyl or a trivalent ethane radical.

  一种具有肌肉松弛活性的四价铵化合物，其化学式表示为(I)：##STR1## 其中R.sub.1表示亚甲基，较低的烷氧基，较低的烯基，较低的炔基，-CO-，-COO-，较低的烷基碳酸酯，-CH（OR.sub.5）-，较低的烷基羰基，羟基较低的烷基，-O-，-S-，-SO-，或-SO.sub.2-; R.sub.2表示氢原子，羟基较低烷基，醛，较低烷基羰基，-NO.sub.2或-NHR.sub.6; R.sub.3表示一羟基原子，属于一群-R.sub.1-(CH.sub.2).sub.a-[CH(CH.sub.2 A)-CH.sub.2].sub.b-A的氢原子; R.sub.4表示一个阴离子; R.sub.5和R.sub.6表示一个氢原子或一个乙酰基; A表示一个四价铵基团; a表示1到8的整数; b表示0或1; m表示1到4的整数; (Z)表示三价苯环，三价萘环，三价二苯基或三价乙烷基团。
• 2-Azetidinone Cholesterol Absorption Inhibitors:  Structure−Activity Relationships on the Heterocyclic Nucleus
  作者：John W. Clader、Duane A. Burnett、Mary Ann Caplen、Martin S. Domalski、Sundeep Dugar、Wayne Vaccaro、Rosy Sher、Margaret E. Browne、Hongrong Zhao、Robert E. Burrier、Brian Salisbury、Harry R. Davis

  DOI：10.1021/jm960405n

  日期：1996.1.1

  A series of azetidinone cholesterol absorption inhibitors related to SCH 48461 ((-)-6) has been prepared, and compounds were evaluated for their ability to inhibit hepatic cholesteryl ester formation in a cholesterol-fed hamster model. Although originally designed as acyl CoA: cholesterol acyltransferase (ACAT) inhibitors, comparison of in vivo potency with in vitro activity in a microsomal ACAT assay indicates no correlation between activity in these two models. The molecular mechanism by which these compounds inhibit cholesterol absorption is unknown. Despite this limitation, examination of the in vivo activity of a range of compounds has revealed clear structure-activity relationships consistent with a well-defined molecular target. The details of these structure-activity relationships and their implications on the nature of the putative pharmacophore are discussed.
• US4400316A
  申请人：——

  公开号：US4400316A

  公开（公告）日：1983-08-23
• US5093370A
  申请人：——

  公开号：US5093370A

  公开（公告）日：1992-03-03
• [EN] DIYNE COMPOSITIONS<br/>[FR] COMPOSITIONS DE DIYNES
  申请人：EVOLVA LTD

  公开号：WO2011134538A1

  公开（公告）日：2011-11-03

  A novel class of diyne compounds and diyne salts provided herein are effective and potent Ole1 protein inhibitors, useful for treating fungal pathogens. Compounds, fungicides and methods are provided as novel, potent and broad spectrum antifungal agents for treatment against a wide variety of fungal pathogens in humans and animals, and in the agricultural setting.